article · Afro-Egyptian Journal of Infectious and Endemic Diseases
Background and study aim: Toxoplasma gondii is a globally distributed parasite that causes oxidative stress as a part of the mechanism of neuropathology. The currently available treatments for toxoplasmosis are of limited efficacy because of its distinct pathophysiology. This study aimed to assess the anti-inflammatory and antioxidant effects of Lepidium sativum seed extract, olive leaves extract, resveratrol, and Eucalyptus either as a monotherapy or in combination with pyrimethamine-sulfadiazine in experimental toxoplasmosis by histopathological and immunohistochemical studies. Patients and Methods: One-hundred-seventy-six Swiss albino mice were divided into eleven experimental groups (16 mice each) as follows Group (1) Control non-infected, Group (2) Control infected, Group (3) infected and treated with pyrimethamine-sulfadiazine, Group (4) infected and treated with RSV, Group (5) infected and treated with Eucalyptus, Group (6) infected and treated with Lepidium sativum, Group(7) infected and treated with olives leaves extract, Group (8) infected and treated with pyrimethamine-sulfadiazine and RSV, Group(9) infected and treated with pyrimethamine-sulfadiazine and Eucalyptus, Group (10) infected and treated with pyrimethamine-sulfadiazine and Lepidium sativum, Group (11) infected and treated with pyrimethamine-sulfadiazine and olives leave extract. Results: Histopathological examination of liver and brain tissues displayed marked improvement in all treated groups with a significant effect on the expression of iNOS and NSE, mainly in olives leaves extract treated groups. Conclusion: Olive leaf extract, Lepidium sativum seed extract, resveratrol, and Eucalyptus can be promising efficient natural alternatives that can ameliorate the histopathological changes and oxidative stress triggered by the parasite during Toxoplasma gondii infection.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/aeji.2024.258749.1346
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.